RPS Terus Memperluas Kepemimpinan Global di Bidang Klinis, Regulasi, Medis, danOperasional

AsiaNet 45592

FORT WASHINGTON, Pa., 20 Juli 2011 /PRNewswire-AsiaNet/ —

ReSearch Pharmaceutical Services, Inc. (RPS), CRO generasi mendatang yang
memberikan solusi pengembangan klinis komprehensif Tahap II-IV global untuk
industri biofarmasi dan peralatan medis, hari ini mengumumkan penambahan
penting berikut ini atas tim Operasional dan Manajemen Seniornya.

– John K. Davis, II, sebagai Chief Information Officer dan Wakil Presiden
Eksekutif, Clinical Systems
– Martine Dehlinger-Kremer, Ph.D. sebagai Wakil Presiden, Urusan Regulasi
Global
– Debra Marshall sebagai Wakil Presiden, Program Klinis dan Manajemen
Lokasi Global
– Lexy Kelley, MD sebagai Direktur Medis, Jasa Pengembangan Imunologi
– Peggy Doran sebagai Direktur Eksekutif, Manajemen Operasi Bisnis R&D

“RPS sangat senang dapat menambahkan tim yang berbakat dan berpengalaman
seperti mereka ke dalam organisasi kami,” kata Harris Koffer, Pharm.D.,
Presiden dan COO. “Penambahan ini akan memperkuat lebih lanjut posisi kami
sebagai pembaru dan penyedia terkemuka solusi pengembangan klinis yang sudah
tertanam (Embedded) dan lengkap (Full-Service) dalam mendukung kebutuhan
pengembangan produk global klien kami yang meluas.”

John K Davis, II membawa pengalaman lebih dari 30 tahun sebagai CIO dan
eksekutif operasi ulung. Sebelumnya beliau bekerja sebagai Wakil Presiden
Senior dan Chief Information Officer di American Board of Internal Medicine
(ABIM) serta Wakil Presiden Eksekutif dan CIO di Omnicare Clinical Research, di
mana beliau memimpin globalisasi Manajemen Data Klinis, Biostatistik, Teknologi
Informasi, Karya Tulis Klinis, serta fungsi Pelatihan.

Martine Dehlinger-Kremer, Ph.D. telah berpengalaman lebih dari 24 tahun
dalam industri farmasi dengan keahlian luas di bidang Urusan Regulasi Global.
Baru-baru ini beliau menjabat sebagai Wakil Presiden Urusan Regulasi Global dan
Urusan Kedokteran Global di Theorem Clinical Research (sebelumnya bernama
Omnicare Clinical Research).

Debra Marshall berpengalaman lebih dari 30 tahun di bidang pengelolaan
industri perawatan kesehatan dan farmasi dan baru-baru ini menjabat sebagai
Asisten Wakil Presiden, bidang Manajemen Lokasi Global di Amerika Serikat untuk
Pfizer (sebelumnya bernama Wyeth), di mana beliau berperan penting dalam
membangun Organisasi Manajemen Lokasi berkinerja tinggi dan meningkatkan
strategi Manajemen Lokasi.

Lexy Kelley, MD membawa pengalaman yang cukup kuat di bidang desain,
implementasi dan pengawasan medis program pengembangan klinis untuk pengobatan
Lupus serta pengalaman penelitian klinis dalam hematologi, penyakit menular,
rematologi (ilmu penyakit otot) dan alergi. Sebelum bergabung dengan RPS,
beliau menjabat sebagai Sejawat Direktur Medis di UCB Pharma.

Marguerite (Peggy) Doran berengalaman lebih dari 25 tahun dalam industri
farmasi, yang mencakup pengalaman 18 tahun dalam negosiasi dan manajemen
kontrak, penerapan strategi sumber daya, optimalisasi kontrak dan perbaikan
proses serta program manajemen hubungan dengan penjual dan tata kelola.

“Karena model bisnis kami yang unik, RPS telah mencapai tingkat
pertumbuhan mengesankan yang jauh melampaui laju pertumbuhan pasar CRO dalam
tahap akhir,” ujar Daniel M. Perlman, Ketua dan CEO. “Penambahan baru pada
organisasi kami merupakan komponen penting fokus kami yang terus-menerus pada
pertumbuhan dan inovasi dalam mendukung industri biofarmasi dan perangkat medis
global.”

Tentang RPS
RPS memberikan solusi pengembangan klinis komprehensif Tahap II-IV global
untuk industri Farmasi, Bioteknologi, Perangkat Medis dan Diagnostik. Dengan
menggabungkan infrastruktur operasi penelitian klinis kami yang sangat
berpengalaman dengan penggerak sumber daya terbesar dalam industri, RPS berada
di posisi unik untuk memberi para pelanggan kami berbagai spektrum solusi
outsourcing. Solusi tersebut berkisar dari program fungsional dan fungsional
silang Embedded di seluruh dunia hingga solusi layanan lengkap global yang
ditingkatkan, dan diperkuat oleh tim proyek sangat berpengalaman yang
memberikan layanan inovatif, tanpa cela, hemat biaya dan berkualitas tinggi.

Dengan lebih dari 3.000 karyawan, RPS beroperasi di 45 negara di seluruh
dunia.

SUMBER ReSearch Pharmaceutical Services, Inc.

KONTAK: Bisnis: Samir Shah, Wakil Presiden Eksekutif, Pengembangan
Strategis, +1-215-540-0700 ext. 3308, sshah@rpsweb.com, atau Kontak Pemasaran &
Media: Sean P. Quinn, Direktur, Pemasaran Korporat, +1-215-540-0700 ext. 3321,
squinn@rpsweb.com


RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership
FORT WASHINGTON, Pa., July 20, 2011 /PRNewswire-AsiaNet/ —

ReSearch Pharmaceutical Services, Inc. (RPS), a next generation CRO that provides comprehensive global Phase II-IV clinical development solutions to the biopharmaceutical and medical device industries, today announced the following key additions to its Operational and Senior Management team.

– John K. Davis, II, as Chief Information Officer and Executive Vice President, Clinical Systems
– Martine Dehlinger-Kremer, Ph.D. as Vice President, Global Regulatory Affairs
– Debra Marshall as Vice President, Clinical Programs and Global Site Management
– Lexy Kelley, MD as Medical Director, Immunology Development Services
– Peggy Doran as Executive Director, R&D Business Operations Management

“RPS is extremely pleased to add such a talented and experienced team to our organization,” said Harris Koffer, Pharm.D., President and COO. “These additions will further strengthen our position as an innovator and leading provider of Embedded and Full-Service clinical development solutions in support of our clients expanding global product development needs.”

John K. Davis, II brings more than 30 years of experience as an accomplished CIO and operations executive. He previously served as Senior Vice President and Chief Information Officer at the American Board of Internal Medicine (ABIM) and Executive Vice President and CIO at Omnicare Clinical Research, where he led the globalization of the Clinical Data Management, Biostatistics, Information Technology, Clinical Writing, and Training functions.

Martine Dehlinger-Kremer, Ph.D. has over 24 years of experience in the pharmaceutical industry with extensive expertise in global Regulatory Affairs. She most recently served as the Vice President of Global Regulatory Affairs and Global Medical Affairs at Theorem Clinical Research (previously Omnicare Clinical Research).

Debra Marshall has over 30 years of healthcare and pharmaceutical industry management experience and most recent served as Assistant Vice President, US Global Site Management for Pfizer (formerly Wyeth), where she was instrumental in building a high performing Site Management Organization and implementing enhanced Site Management strategies.

Lexy Kelley, MD brings strong experience in the design, implementation and medical oversight of clinical development programs for the treatment of Lupus as well as clinical research experience in hematology, infectious diseases, rheumatology and allergy. Prior to joining RPS, she served as an Associate Medical Director at UCB Pharma.

Marguerite (Peggy) Doran has over 25 years of pharmaceutical industry experience, including 18 years of experience in contract negotiation and management, implementation of sourcing strategies, contract optimization and process improvements as well as vendor relationship management and governance programs.

“Because of our unique business model, RPS has achieved impressive growth rates that far exceed those in the late stage CRO marketplace,” said Daniel M. Perlman, Chairman and CEO. “The new additions to our organization are a key component of our continued focus on growth and innovation in support of the global biopharmaceutical and medical device industries.”

About RPS
RPS provides comprehensive global Phase II-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries. By combining our highly experienced clinical research operations infrastructure with the industry’s largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services.

With more than 3,000 employees, RPS operates in 45 countries across the globe.

SOURCE: ReSearch Pharmaceutical Services, Inc.

CONTACT: Business: Samir Shah, Executive Vice President, Strategic Development, +1-215-540-0700 ext. 3308, sshah@rpsweb.com, or Marketing & Media Contact: Sean P. Quinn, Director, Corporate Marketing, +1-215-540-0700 ext. 3321, squinn@rpsweb.com